Advertisement

Acta Neurochirurgica

, Volume 80, Issue 3–4, pp 123–127 | Cite as

Thymidine kinase in extracts of human brain tumours

  • L. Persson
  • S. J. Gronowitz
  • C. F. R. Källander
Clinical and Laboratory Research

Summary

Deoxythymidine kinase (TK) is an enzyme involved in DNA synthesis. It can be used as a marker of cell proliferation. TK was measured in extracts of human brain tumours and non-neoplastic brain tissue. In astrocytomas the mean TK activity increased with increasing grade of malignancy. Oligodendrogliomas showed higher TK activity than astrocytomas. The highest activities were noted in menigiomas, of which the recurrent ones exceeded the primary in TK activity. In non-neoplastic brain tissue lower TK activity was found. It is concluded that TK can be measured in human brain tumour extracts, and is potentially of use for studies on tumour cell proliferation.

Keywords

Thymidine kinase brain tumours glioma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bello, L. J., Regulation of thymidine synthesis in human cells. Expl. Cell. Res.89 (1974), 263.Google Scholar
  2. 2.
    Cronkite, E. P., Fairchild, R. G., Miller, M. E., Are there unexploited possibilities for the therapeutic use of radiactive and stable isotopically labeled DNA precursors and extracorporal irradiation of the blood in treatment of leukemia. Blood Cells9 (1983), 107–123.PubMedGoogle Scholar
  3. 3.
    Djordjevic, B., Szybalski, W., Genetics of human cell lines. III. J. exp. Med.112 (1960), 509–531.PubMedGoogle Scholar
  4. 4.
    Fredriksen, P., Reske-Nielsen, E., Bichel, P., Flow cytometry in tumours of the brain. Acta Neuropathologica (Berl.)4 (1978), 179–183.Google Scholar
  5. 5.
    Gronowitz, J. S., Källander, C. F. R., Diderholm, H., Hagberg, H., Pettersson, U., Application of an in vitro assay for serum thymidine kinase: Results on viral disease and malignancies in humans. Int. J. Cancer33 (1984), 5–12.PubMedGoogle Scholar
  6. 6.
    Gronowitz, J. S., Källander, C. F. R., Hagberg, H., Persson, L., Deoxythymidine kinase in cerebrospinal fluid: A new potential “marker” for brain tumours. Acta Neurochir. (Wien)73 (1984), 1–12.Google Scholar
  7. 7.
    Jellinger, K., Slowik, F., Histological subtypes and prognostic problems in meningiomas. J. Neurol.208 (1975), 279–298.PubMedGoogle Scholar
  8. 8.
    Munch-Petersen, B., Tyrstedt, G.: Induction of thymidine kinases in phytohaemaglutinin stimulated lymphocytes. Biochem. Biophys. Acta478 (1977), 364.PubMedGoogle Scholar
  9. 9.
    Persson, L., Boëthius, J., Gronowitz, J. S., Källander, C. F. R., Lindgren, L., Thymidine kinase in brain tumour cysts. J. Neurosurg.63 (1985), 568–572.PubMedGoogle Scholar
  10. 10.
    Rubinstein, L. J., Tumours of the central nervous system. Atlas of the tumour pathology, edn. 2. Washington: Armed Forces Institute of Pathology. 1972.Google Scholar
  11. 11.
    Russo, A., Gianni, L., Kinsella, T.,et al., Pharmacological evaluation of intravenous delivery of 5-bromdeoxyuridine to patients with brain tumours. Cancer Res.44 (1984), 1702–1705.PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1986

Authors and Affiliations

  • L. Persson
    • 1
  • S. J. Gronowitz
    • 2
  • C. F. R. Källander
    • 2
  1. 1.Department of NeurosurgerySödersjukhusetStockholm
  2. 2.Department of Medical VirologyUniversity of UppsalaUppsalaSweden

Personalised recommendations